Vorinostat Completed Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00656617 | Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) |